search
Back to results

Opiate Sparing Protocol Randomized Controlled Trial in Open Distal Radius Fracture Repair

Primary Purpose

Distal Radius Fracture

Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Opiate Sparing
Opiate Based
Sponsored by
Campbell Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Distal Radius Fracture

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Open reduction internal fixation surgery at Campbell Clinic Surgery Center
  • Body Mass Index less than or equal to 45
  • Fluent in verbal and written English

Exclusion Criteria:

  • Known sensitivity to medications in either protocol
  • Renal disease by medical history
  • Concomitant ipsilateral upper extremity injury or condition other than wrist
  • Chronic pain syndrome
  • Consumption of ten consecutive day so opioid use in the previous 90 days
  • Worker's compensation
  • Women who are pregnant, planning to become pregnant, or are breastfeeding
  • Takes either angiotensin-converting enzyme inhibitor or angiotensin II receptor blockers for hypertension

Sites / Locations

  • Campbell Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Opiate Sparing

Opiate Based

Arm Description

Standard icing and elevation therapy Acetaminophen 1000 milligrams by mouth every 8 hours for five days then as needed every 8 hours for pain control Gabapentin 100 milligrams by mouth three times per day for 14 days Celecoxib 100 milligrams by mouth two times per day for 5 days Esomeprazole 20 milligrams by mouth once per day for 14 days Promethazine 12.5 milligrams by mouth every 8 hours as needed for nausea or vomiting Docusate 100 milligrams by mouth two times per day while taking oxycodone Oxycodone 5 milligrams by mouth every 6 hours as needed for pain control unresponsive to other medications

Standard icing and elevation therapy Oxycodone 5-10 milligrams by mouth every 4 to 6 hours as needed for pain control Acetaminophen 1000 milligrams by mouth every 8 hours as needed for pain control Promethazine 12.5 milligrams by mouth every 8 hours as needed for nausea or vomiting Docusate 100 milligrams by mouth two times per day while taking oxycodone

Outcomes

Primary Outcome Measures

Oral Morphine Equivalent
opiate pill count
Oral Morphine Equivalent
opiate pill count
Oral Morphine Equivalent
opiate pill count

Secondary Outcome Measures

Visual Analog Score
Patient reported pain score from 0 to 10 where 0 is no pain and 10 is the most pain
Visual Analog Score
Patient reported pain score from 0 to 10 where 0 is no pain and 10 is the most pain
Visual Analog Score
Patient reported pain score from 0 to 10 where 0 is no pain and 10 is the most pain

Full Information

First Posted
January 18, 2022
Last Updated
August 3, 2023
Sponsor
Campbell Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT05215236
Brief Title
Opiate Sparing Protocol Randomized Controlled Trial in Open Distal Radius Fracture Repair
Official Title
Prospective, Randomized, Controlled Trial of an Opiate Sparing Protocol Versus Standard Opiate Based Protocol Following Open Reduction Internal Fixation of Distal Radius Fractures
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
March 1, 2022 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
March 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Campbell Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
A comparison of oral morphine equivalents between an opiate sparing cohort and an opiate based cohort following open reduction internal fixation of a distal radius fracture.
Detailed Description
Recently, the opioid epidemic has been the center of focus for healthcare providers and governmental agencies due to rising rates of opioid abuse, opioid-related fatalities, and overall economic burden of treating the opioid epidemic. The prescribing patterns of opioid pain medications have fallen under scrutiny and healthcare providers have sought alternative pain management strategies that have limited opioid pain medication use. As orthopaedic surgeons account for 7.7% of all dispensed opioid prescriptions within the United States, surgeons have investigated multimodal pain management strategies to assess effectiveness in controlling postoperative pain as well as limiting opioid use and opioid related complications. The literature documents the safety and effectiveness of non-steroid anti-inflammatory drugs (NSAID) and acetaminophen in soft tissue hand procedures and distal radius fracture plating. Currently, there remains no clear consensus on the ideal pain management strategy following open reduction internal fixation (ORIF) of distal radius fractures and the vast majority of strategies are based on opiate-driven protocols. This study will investigate the effectiveness of an opiate sparing protocol following open reduction and internal fixation (ORIF) of distal radius fractures on opiate consumption as measured by oral morphine equivalents at the 2, 6 and 12 week postoperative time point through collection of pill counts. Secondary outcomes are pain scores, patient satisfaction, and safety reporting (complications, reoperations, and readmissions) during the 12-week episode-of-care. This study will document the safety and effectiveness of an opiate sparing, multimodal pain management protocol in properly selected patients undergoing ORIF of distal radius fractures. Following written consent documentation, Subjects will be randomized to either the opiate sparing cohort or the opiate based cohort at a 1:1 randomization. No blinding will occur as part of the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Distal Radius Fracture

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
72 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Opiate Sparing
Arm Type
Experimental
Arm Description
Standard icing and elevation therapy Acetaminophen 1000 milligrams by mouth every 8 hours for five days then as needed every 8 hours for pain control Gabapentin 100 milligrams by mouth three times per day for 14 days Celecoxib 100 milligrams by mouth two times per day for 5 days Esomeprazole 20 milligrams by mouth once per day for 14 days Promethazine 12.5 milligrams by mouth every 8 hours as needed for nausea or vomiting Docusate 100 milligrams by mouth two times per day while taking oxycodone Oxycodone 5 milligrams by mouth every 6 hours as needed for pain control unresponsive to other medications
Arm Title
Opiate Based
Arm Type
Active Comparator
Arm Description
Standard icing and elevation therapy Oxycodone 5-10 milligrams by mouth every 4 to 6 hours as needed for pain control Acetaminophen 1000 milligrams by mouth every 8 hours as needed for pain control Promethazine 12.5 milligrams by mouth every 8 hours as needed for nausea or vomiting Docusate 100 milligrams by mouth two times per day while taking oxycodone
Intervention Type
Other
Intervention Name(s)
Opiate Sparing
Intervention Description
Subjects will receive non-opiate medications for pain control
Intervention Type
Other
Intervention Name(s)
Opiate Based
Intervention Description
Subjects will receive opiate based medications for pain control
Primary Outcome Measure Information:
Title
Oral Morphine Equivalent
Description
opiate pill count
Time Frame
postoperative day to two week visit
Title
Oral Morphine Equivalent
Description
opiate pill count
Time Frame
two week to six week visit
Title
Oral Morphine Equivalent
Description
opiate pill count
Time Frame
six week to twelve week visit
Secondary Outcome Measure Information:
Title
Visual Analog Score
Description
Patient reported pain score from 0 to 10 where 0 is no pain and 10 is the most pain
Time Frame
postoperative day to two week visit
Title
Visual Analog Score
Description
Patient reported pain score from 0 to 10 where 0 is no pain and 10 is the most pain
Time Frame
six week visit
Title
Visual Analog Score
Description
Patient reported pain score from 0 to 10 where 0 is no pain and 10 is the most pain
Time Frame
twelve week visit
Other Pre-specified Outcome Measures:
Title
Incidence of treatment-emergent adverse event
Description
monitoring for safety events
Time Frame
postoperative day to two week visit
Title
Incidence of treatment-emergent adverse event
Description
monitoring for safety events
Time Frame
two week to six week visit
Title
Incidence of treatment-emergent adverse event
Description
monitoring for safety events
Time Frame
six week to twelve week visit
Title
Patient satisfaction Score
Description
patient reported satisfaction with pain management from 0 to 10 where 0 is very unsatisfied and 10 is very satisfied
Time Frame
postoperative day to two week visit
Title
Patient satisfaction Score
Description
patient reported satisfaction with pain management from 0 to 10 where 0 is very unsatisfied and 10 is very satisfied
Time Frame
two week to six week visit
Title
Patient satisfaction Score
Description
patient reported satisfaction with pain management from 0 to 10 where 0 is very unsatisfied and 10 is very satisfied
Time Frame
six week to twelve week visit

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Open reduction internal fixation surgery at Campbell Clinic Surgery Center Body Mass Index less than or equal to 45 Fluent in verbal and written English Exclusion Criteria: Known sensitivity to medications in either protocol Renal disease by medical history Concomitant ipsilateral upper extremity injury or condition other than wrist Chronic pain syndrome Consumption of ten consecutive day so opioid use in the previous 90 days Worker's compensation Women who are pregnant, planning to become pregnant, or are breastfeeding Takes either angiotensin-converting enzyme inhibitor or angiotensin II receptor blockers for hypertension
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William J Weller, MD
Organizational Affiliation
Campbell Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Campbell Clinic
City
Germantown
State/Province
Tennessee
ZIP/Postal Code
38138
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26869374
Citation
Galos DK, Taormina DP, Crespo A, Ding DY, Sapienza A, Jain S, Tejwani NC. Does Brachial Plexus Blockade Result in Improved Pain Scores After Distal Radius Fracture Fixation? A Randomized Trial. Clin Orthop Relat Res. 2016 May;474(5):1247-54. doi: 10.1007/s11999-016-4735-1. Epub 2016 Feb 11.
Results Reference
background
PubMed Identifier
31733939
Citation
Martinez L, Ekman E, Nakhla N. Perioperative Opioid-sparing Strategies: Utility of Conventional NSAIDs in Adults. Clin Ther. 2019 Dec;41(12):2612-2628. doi: 10.1016/j.clinthera.2019.10.002. Epub 2019 Nov 14.
Results Reference
background
PubMed Identifier
33552691
Citation
Niedermeier SR, Crouser N, Hidden K, Jain SA. Pain Management following Open Reduction and Internal Fixation of Distal Radius Fractures. J Wrist Surg. 2021 Feb;10(1):27-30. doi: 10.1055/s-0040-1716508. Epub 2020 Oct 14.
Results Reference
background
PubMed Identifier
28235120
Citation
O'Neil JT, Wang ML, Kim N, Maltenfort M, Ilyas AM. Prospective Evaluation of Opioid Consumption After Distal Radius Fracture Repair Surgery. Am J Orthop (Belle Mead NJ). 2017 Jan/Feb;46(1):E35-E40.
Results Reference
background
PubMed Identifier
31311667
Citation
Padilla JA, Gabor JA, Schwarzkopf R, Davidovitch RI. A Novel Opioid-Sparing Pain Management Protocol Following Total Hip Arthroplasty: Effects on Opioid Consumption, Pain Severity, and Patient-Reported Outcomes. J Arthroplasty. 2019 Nov;34(11):2669-2675. doi: 10.1016/j.arth.2019.06.038. Epub 2019 Jun 26.
Results Reference
background
PubMed Identifier
29406338
Citation
Sabatino MJ, Kunkel ST, Ramkumar DB, Keeney BJ, Jevsevar DS. Excess Opioid Medication and Variation in Prescribing Patterns Following Common Orthopaedic Procedures. J Bone Joint Surg Am. 2018 Feb 7;100(3):180-188. doi: 10.2106/JBJS.17.00672.
Results Reference
background
PubMed Identifier
30747964
Citation
Thybo KH, Hagi-Pedersen D, Dahl JB, Wetterslev J, Nersesjan M, Jakobsen JC, Pedersen NA, Overgaard S, Schroder HM, Schmidt H, Bjorck JG, Skovmand K, Frederiksen R, Buus-Nielsen M, Sorensen CV, Kruuse LS, Lindholm P, Mathiesen O. Effect of Combination of Paracetamol (Acetaminophen) and Ibuprofen vs Either Alone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty: The PANSAID Randomized Clinical Trial. JAMA. 2019 Feb 12;321(6):562-571. doi: 10.1001/jama.2018.22039.
Results Reference
background

Learn more about this trial

Opiate Sparing Protocol Randomized Controlled Trial in Open Distal Radius Fracture Repair

We'll reach out to this number within 24 hrs